Oxford Nanopore Technologies Ltd. ADR (OXFYY)
Market Closed
12 Jun, 20:00
OTC PINK OTC PINK Primary $
6. 50
-0.88
-11.9241%
$
1.46B Market Cap
- P/E Ratio
- Div Yield
250 Volume
- Eps
$ 7.38
Previous Close Want to track OXFYY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
OXFYY closed Friday lower at $6.5, a decrease of -11.9241% from Thursday's close, completing a monthly decrease of -11.9241% or -$0.88. Over the past 12 months, OXFYY stock lost -7.1429%.
OXFYY is not paying dividends to its shareholders.
The last earnings report, released on Mar 02, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
Oxford Nanopore Technologies Ltd. ADR (OXFYY) FAQ
What is the stock price today?
The current price is $6.50.
On which exchange is it traded?
Oxford Nanopore Technologies Ltd. ADR is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is OXFYY.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 1.46B.
Has Oxford Nanopore Technologies Ltd. ADR ever had a stock split?
No, there has never been a stock split.
Oxford Nanopore Technologies Ltd. ADR Profile
| Health Care Technology Industry | Healthcare Sector | Mr. Nicholas Patrick Keher CEO | OTC PINK Exchange | - ISIN |
| US Country | 1,335 Employees | - Last Dividend | - Last Split | - IPO Date |
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its customers to perform scientific/biomedical research in a various area, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. It operates in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Contact Information
Address: Gosling Building, Oxford, United Kingdom, OX4 4DQ
Phone: 44 84 5034 7900
Website: https://nanoporetech.com
